News

Angioline company became a general sponsor of the III international course on modern trends in treatment of acute myocardial infarction with st-segment elevation (stemi) – from theory to day-to-day practice

09.10.2015, Moscow. The CALIPSO stents were used in the live online broadcasting surgeries at the III International Course on Modern Trends in Managing Acute Myocardial Infarction. The surgeries were performed by A.G. Kaledinsky (MCH #7), S.P. Semitko (MCH #81) and I. Kovalchuk (Interventional Cardiology SPC). The ANGIOLINE Company became the general sponsor of the III International Course on Modern Trends in Treatment of Acute Myocardial Infarction with ST-Segment Elevation (STEMI) – from Theory to Day-to-Day Practice. 

Three surgical procedures using the CALIPSO stents manufactured by the ANGIOLINE Company were performed within the framework of the Conference, traditionally organized by the Russian Scientific Society of Interventional Cardioangiologists, that gathered about 200 representatives of the medical community. The CALIPSO stents have the bioresorbable coating eluting the Sirolimus medicine. All three surgeries were a success, despite a number of unfavorable factors. 

The first surgery using the CALIPSO stents took place at 9:00 a.m. It was performed by Anton Gennadyevich Kaledinsky at the Municipal Clinical Hospital #7. 72-year-old female patient has received 4 stents, two of which were CALIPSO stents. The surgery was a success. 

The second patient who underwent a surgery was a 51-year-old man diagnosed with acute myocardial infarction. The pain lasted for about two hours. The man was a smoker, which was an additional risk factor for percutaneous interventions. The stenting was performed by Sergey Semitko, at the MCH #81, in the curvature of the artery that, by itself, is a rather problematic case. The attempts to pass the stent without pre-dilatation failed. However, once the pre-dilatation had been performed with the guide-catheter being passed close to stenosis, the stent was placed with a good result. 

The third patient, a 55-year-old man, was urgently hospitalized with a diagnosis of ‘acute myocardial infarction’. The primary medical treatment gave no specific results. The operation was performed by Ilya Kovalchuk at the Scientific and Practical Center of Interventional Cardiology. Among the additional negative prognosis factors was acute right occlusion with signs of thrombosis, that, in the doctor’s opinion, had become the cause of infarction. The stent placement surgery for that patient was also a success. The members of the Panel evaluated the risks as minimal.